Lincoln National Corp Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Lincoln National Corp boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 9,063 shares of the medical equipment provider’s stock after purchasing an additional 1,358 shares during the period. Lincoln National Corp’s holdings in Intuitive Surgical were worth $3,057,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the stock. Fielder Capital Group LLC purchased a new position in Intuitive Surgical during the fourth quarter valued at $841,000. Maryland State Retirement & Pension System lifted its position in Intuitive Surgical by 1.1% during the fourth quarter. Maryland State Retirement & Pension System now owns 27,190 shares of the medical equipment provider’s stock valued at $9,173,000 after purchasing an additional 289 shares in the last quarter. MeadowBrook Investment Advisors LLC purchased a new position in Intuitive Surgical during the fourth quarter valued at $30,000. Spire Wealth Management purchased a new position in Intuitive Surgical during the fourth quarter valued at $1,987,000. Finally, Clearstead Trust LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at about $583,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. Mizuho boosted their price objective on Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Thursday, January 25th. Robert W. Baird lowered their price objective on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research report on Friday, April 19th. Barclays boosted their price objective on Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research report on Thursday, January 25th. Royal Bank of Canada boosted their price objective on Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a research report on Wednesday, January 24th. Finally, Jefferies Financial Group boosted their target price on Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research report on Friday, April 19th. Five investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $396.17.

Insider Transactions at Intuitive Surgical

In other news, Director Alan J. Levy sold 2,000 shares of the stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the sale, the director now directly owns 25,319 shares in the company, valued at $9,385,753.30. The sale was disclosed in a document filed with the SEC, which is available at this link. In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of the firm’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total transaction of $741,400.00. Following the transaction, the director now directly owns 25,319 shares in the company, valued at approximately $9,385,753.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Mark Brosius sold 196 shares of the firm’s stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total value of $78,400.00. Following the transaction, the senior vice president now owns 1,842 shares in the company, valued at $736,800. The disclosure for this sale can be found here. Over the last three months, insiders have sold 228,637 shares of company stock worth $88,483,248. 0.80% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG traded up $5.60 during trading on Tuesday, hitting $388.65. The company had a trading volume of 932,707 shares, compared to its average volume of 1,608,281. The stock has a market cap of $137.86 billion, a price-to-earnings ratio of 69.79, a price-to-earnings-growth ratio of 4.93 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $403.76. The company has a fifty day simple moving average of $385.29 and a two-hundred day simple moving average of $351.11.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same period in the prior year, the business posted $1.00 earnings per share. The company’s revenue for the quarter was up 11.5% on a year-over-year basis. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.